Wockhardt Company Profile
✉ Email this page to a colleague
What is the competitive landscape for WOCKHARDT
WOCKHARDT has seventy-six approved drugs.
There are seven US patents protecting WOCKHARDT drugs. There are three tentative approvals on WOCKHARDT drugs.
Summary for Wockhardt
| US Patents: | 7 |
| Tradenames: | 57 |
| Ingredients: | 54 |
| NDAs: | 76 |
| Patent Litigation for Wockhardt: | See patent lawsuits for Wockhardt |
| PTAB Cases with Wockhardt as petitioner: | See PTAB cases with Wockhardt as petitioner |
Drugs and US Patents for Wockhardt
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Wockhardt Bio Ag | LINDANE | lindane | SHAMPOO;TOPICAL | 088191-001 | Sep 18, 1984 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | |||||
| Wockhardt | CLARITHROMYCIN | clarithromycin | TABLET;ORAL | 065266-002 | May 31, 2006 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | |||||
| Wockhardt Bio Ag | LISINOPRIL | lisinopril | TABLET;ORAL | 078402-001 | Apr 19, 2007 | AB | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ||||
| Wockhardt | CEFOTAXIME | cefotaxime sodium | INJECTABLE;INJECTION | 065197-001 | Aug 29, 2006 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | |||||
| Wockhardt Bio Ag | DECITABINE | decitabine | INJECTABLE;INTRAVENOUS | 209056-001 | Apr 9, 2019 | AP | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ||||
| Wockhardt Eu Operatn | ALBUTEROL SULFATE | albuterol sulfate | SOLUTION;INHALATION | 075394-001 | Nov 22, 1999 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | |||||
| Wockhardt Bio Ag | OXACILLIN SODIUM | oxacillin sodium | INJECTABLE;INJECTION | 207148-001 | Nov 24, 2017 | AP | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
International Patents for Wockhardt Drugs
| Country | Patent Number | Estimated Expiration |
|---|---|---|
| European Patent Office | 2748165 | ⤷ Start Trial |
| Brazil | 112016008979 | ⤷ Start Trial |
| Japan | 2018080180 | ⤷ Start Trial |
| Australia | 2014338612 | ⤷ Start Trial |
| Poland | 3060213 | ⤷ Start Trial |
| World Intellectual Property Organization (WIPO) | 2015059643 | ⤷ Start Trial |
| South Africa | 201506483 | ⤷ Start Trial |
| >Country | >Patent Number | >Estimated Expiration |
Supplementary Protection Certificates for Wockhardt Drugs
| Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
|---|---|---|---|---|
| 2316456 | 2017C/064 | Belgium | ⤷ Start Trial | PRODUCT NAME: NALTREXONE/BUPROPION; AUTHORISATION NUMBER AND DATE: EU/1/14/988 20150330 |
| 1304992 | C300617 | Netherlands | ⤷ Start Trial | PRODUCT NAME: COMBINATIE VAN CLINDAMYCINE, DESGEWENST IN DE VORM VAN CLINDAMYCINEFOSFAAT EN TRETINOINE; NAT. REGISTRATION NO/DATE: RVG 109745 20130626; FIRST REGISTRATION: PA1332/043/001 20130322 |
| 2316456 | SPC/GB17/078 | United Kingdom | ⤷ Start Trial | PRODUCT NAME: NALTREXONE OR A PHARMACEUTICALLY ACCEPTABLE SALT THEREOF, IN PARTICULAR NALTREXONE HYDROCHLORIDE, AND BUPROPION OR A PHARMACEUTICALLY ACCEPTABLE SALT THEREOF, IN PARTICULAR BUPROPION HYDROCHLORIDE.; REGISTERED: UK EU/1/14/988 20150330; UK PLGB 50742/0001 20150330 |
| 0443983 | C300445 | Netherlands | ⤷ Start Trial | PRODUCT NAME: VALSARTAN, AMLODIPINE EN HYDROCHLOORTHIAZIDE EN FARMACEUTISCH AANVAARDBARE ZOUTEN DAARVAN; REGISTRATION NO/DATE: EU/1/09/569/001-060 20091016 |
| 1534313 | 300784 | Netherlands | ⤷ Start Trial | PRODUCT NAME: KETOROLAC, OF HET TROMETAMOLZOUT ERVAN, EN FENYLEFRINE, OF HET HYDROCHLORIDEZOUT ERVAN; REGISTRATION NO/DATE: EU/1/15/1018 20150730 |
| 3490560 | CA 2025 00023 | Denmark | ⤷ Start Trial | PRODUCT NAME: NIRAPARIB OR A PHARMACEUTICALLY ACCEPTABLE SALT THEREOF IN PARTICULAR NIRAPARIB TOSYLATE IN PARTICU-LAR NIRAPARIB TOSYLATE MONOHYDRATE, OPTIONALLY IN COMBINATION WITH ABIRATERONE IN PARTICULAR ABI-RATERONE ACETATE; REG. NO/DATE: EU/1/23/1722 20230420 |
| 0617614 | 2001/009 | Ireland | ⤷ Start Trial | PRODUCT NAME: PANRETIN-ALITRETINOIN |
| >Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
